Inter Parfums (IPAR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for September 17, 2024, to address director elections, executive compensation, company name change, auditor ratification, and other business.
Proxy materials and annual report for fiscal year ended December 31, 2023, are available online; shareholders of record as of July 22, 2024, are eligible to vote.
Board recommends voting in favor of all proposals, including the election of nine directors, advisory approval of executive compensation, company name change, and auditor ratification.
Voting matters and shareholder proposals
Proposals include electing nine directors, advisory vote on executive compensation, changing the company name to Interparfums, Inc., and ratifying Forvis Mazars, LLP as independent auditor.
Shareholders may submit proposals for the 2025 annual meeting between June 19, 2025, and July 1, 2025.
Major shareholders Jean Madar and Philippe Benacin intend to vote in favor of all management proposals, making passage likely.
Board of directors and corporate governance
Board consists of nine directors, including independent members; all current directors are nominated for re-election.
Board committees include Audit, Executive Compensation and Stock Option, and Nominating Committees, all with posted charters.
Board diversity policy revised in 2024; current board meets Nasdaq diversity requirements.
Code of Conduct and insider trading policies are in place and available to shareholders.
Board held 19 meetings in 2023, with all directors attending at least 75% of meetings.
Latest events from Inter Parfums
- Record sales and EPS in FY2025, with strong brand growth and steady 2026 outlook.IPAR
Q4 202525 Feb 2026 - Record Q2 sales and margin gains support strong outlook and new launches for 2025.IPAR
Q2 20242 Feb 2026 - Record sales, robust innovation, and 4% growth outlook with higher dividend for 2025.IPAR
Q4 20242 Feb 2026 - Q1 2025 net sales up 5%, net income $42.5M, margins and guidance strong, key licenses renewed.IPAR
Q1 20252 Feb 2026 - Q3 2025 sales up 1%, net income up 6%, FY2025 sales seen at $1.47B, EPS $5.12.IPAR
Q3 202520 Jan 2026 - Record Q3 sales and net income up 17%, with 2024 guidance reaffirmed and strong holiday outlook.IPAR
Q3 202415 Jan 2026 - Annual meeting to vote on directors, executive pay, and share cancellation, with board support.IPAR
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay approval, and cancellation of 'hook shares.'IPAR
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, pay, name change, and auditor, all board-recommended.IPAR
Proxy Filing1 Dec 2025